2019-nCoVIgM/IgG (25 Tests)

Cost Per test is

Novel Coronavirus (2019-nCoV) IgM/IgG antibody Fast Test Kit (Immunofluorescence Assay) is intended for the quantitative detection of 2019-Novel Coronavirus IgM and IgG antibody in serum, plasma or whole blood samples from patients suspected of COVID-19 infection by a healthcare provider.
Novel Coronavirus (2019-nCoV) IgM/IgG antibody Fast Test Kit (Immunofluorescence Assay) is an aid in the diagnosis of patients with suspected 2019-nCoV infection in conjunction with clinical presentation and the results of other laboratory tests. This test is only intended for professional and laboratory use, not for home testing. Results from the test should not be used as the sole basis for diagnosis and exclusion of 2019-nCoV infection.

Negative results do not exclude 2019-nCoV infection and should not be used as the sole basis for patient management decisions. IgM antibodies may not be detected in the first few days of infection.

False positive results for IgM and IgG antibodies may occur due to cross-reactivity from pre-existing antibodies or other possible causes. Test results should always be considered in the context of clinical observations and epidemiological data in making a final diagnosis and patient management decisions.

Description

The novel coronaviruses belong to the B genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

When IgM antibodies are present, it may indicate that a patient has an active or recent infection with 2019-Cov. And IgG antibodies develop later following infection. When IgG antibodies are present, it often indicates a past infection but does not exclude recently infected patients who are still contagious, especially if detected with IgM antibodies. It is unknown how long IgM or IgG antibodies to 2019-nCoV will remain present in the body after infection and if they confer immunity to infection.

As it is a novel disease diagnosis of which is being explored, please refer to the latest guidelines for diagnosis and treatment of COVID-19.

Here is the list of references for 2019-nCoVIgM/IgG (25 Tests)
Specifications View